REYON Pharmaceutical Co., Ltd. (KRX:102460)
South Korea · Delayed Price · Currency is KRW 10,040
-50 (-0.50%)
Sep 11, 2026, 3:30 PM KST
REYON Pharmaceutical Market Cap
REYON Pharmaceutical has a market cap or net worth of 184.14 billion as of September 11, 2026. Its market cap has decreased by -14.77% in one year.
Market Cap
184.14B
Enterprise Value
393.96B
Revenue
143.37B
Ranking
n/a
PE Ratio
n/a
Stock Price
10,040.00
ChartMarket Cap Chart
Since June 10, 2010, REYON Pharmaceutical's market cap has increased from 164.55B to 184.14B, an increase of 11.90%. That is a compound annual growth rate of 0.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 184.14B | -6.86% |
| Dec 30, 2025 | 197.72B | -16.04% |
| Dec 30, 2024 | 235.50B | -22.37% |
| Dec 28, 2023 | 303.36B | -21.07% |
| Dec 29, 2022 | 384.35B | -39.10% |
| Dec 30, 2021 | 631.11B | 61.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HLB Pharmaceutical | 216.47B |
| Yungjin Pharm. | 196.24B |
| Whan In Pharm | 190.94B |
| BNC KOREA | 186.72B |
| Chong Kun Dang Holdings | 185.66B |
| AptaBio Therapeutics | 178.39B |
| FutureChem Co.,Ltd | 177.81B |
| JW Lifescience | 171.26B |